Skip to main content

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants with Huntington¿s Disease

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Movement Disorders

Awarded By

Sage Therapeutics

Start Date

March 3, 2022

End Date

December 31, 2024
 

Administered By

Neurology, Movement Disorders

Awarded By

Sage Therapeutics

Start Date

March 3, 2022

End Date

December 31, 2024